Editorial

Buckeridge, Marcos Silveira

doi:10.1590/s0100-84042003000100001

Search citation statements

Order By: Relevance

Paper Sections

Select...

Introduction1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2011

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In Latin America, the number of known sources of galactomannans is small, despite the rich biodiversity of the local flora and the favorable climate for their production. [31][32][33][34][35][36][37][38][39][40][41][42][43][44] In 2008, Brazil imported approximately US$ 142,000 of total polysaccharides but exported only U$ 68,000. Guar imports represented US$ 18,000 over the five-year period of 1993-2007 and around 10,000 tons, at a price of U$ 1.9/kg.…”

Section: Introductionmentioning

confidence: 99%

Pharmaceutical use of galactomannans

Silveira¹,

Bresolin²

2011

Quím. Nova

View full text Add to dashboard Cite

Recebido em 5/1/10; aceito em 13/8/10; publicado na web em 26/11/10 PHARMACEUTICAL USE OF GALACTOMANNANS. The pharmaceutical use of galactomannans from different sources, commercial and noncommercial, has been extensively studied over the past decade. Galactomannans show potential in the global trend towards the use of more plant-based products for ecological motives, and their production and application do not cause pollution or disturb the ecosystem. There is a variety of galactomannan sources and various pharmaceutical forms of application, such as tablets or capsules, hydrogels and films. Besides the simple use as inert excipient this polysaccharides play role in the modification of drug release, especially in colonic environmental, as a matrix or coating material.

show abstract